
|Videos|November 4, 2021
Glucose-Lowering Agents Nothing Short of Beneficial for Advanced CKD Patients
Galindo explained how the use of glucose-lowering agents in patients with diabetes and low eGFR improved patient care.
Advertisement
Pharmacy Times spoke to Rodolfo Galindo, MD, associate professor at the Emory School of Medicine, about his session at the ASN 2021 conference titled "Use of Glucose-Lowering Agents and Glycemic Monitoring in Advanced CKD.”
Galindo explained how the use of glucose-lowering agents in patients with diabetes and low eGFR improved patient care.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
How Subcutaneous Isatuximab Could Compete With Daratumumab in Multiple Myeloma
2
What Does the FDA Advisory Committee’s Vote on 7 Peptides Mean for Pharmacy Practice?
3
Beyond Off-Label: How Auvelity's Approval Changes Agitation Management in Alzheimer Disease
4
FDA Approves SimpleScreen CRC Blood Test for Colorectal Cancer Screening
5











































































































